These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Building up analgesia in humans via the endogenous μ-opioid system by combining placebo and active tDCS: a preliminary report. DosSantos MF; Martikainen IK; Nascimento TD; Love TM; DeBoer MD; Schambra HM; Bikson M; Zubieta JK; DaSilva AF PLoS One; 2014; 9(7):e102350. PubMed ID: 25029273 [TBL] [Abstract][Full Text] [Related]
4. Investigation of [ Kelleher AC; Pearson TD; Ramsey J; Zhao W; O'Conor KA; Bakhoda A; Stodden T; Guo M; Eisenberg SM; Shah SV; Freaney ML; Kim W; Kang Y; Tomasi D; Johnson C; Fang CA; Volkow ND; Kim SW Sci Rep; 2024 Jul; 14(1):16250. PubMed ID: 39009645 [TBL] [Abstract][Full Text] [Related]
5. [ Sun L; Aarnio R; Herre EA; Kärnä S; Palani S; Virtanen H; Liljenbäck H; Virta J; Honkaniemi A; Oikonen V; Han C; Laurila S; Bucci M; Helin S; Yatkin E; Nummenmaa L; Nuutila P; Tang J; Roivainen A Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):266-274. PubMed ID: 36166079 [TBL] [Abstract][Full Text] [Related]
7. Social Laughter Triggers Endogenous Opioid Release in Humans. Manninen S; Tuominen L; Dunbar RI; Karjalainen T; Hirvonen J; Arponen E; Hari R; Jääskeläinen IP; Sams M; Nummenmaa L J Neurosci; 2017 Jun; 37(25):6125-6131. PubMed ID: 28536272 [TBL] [Abstract][Full Text] [Related]
8. Total-body imaging of mu-opioid receptors with [ Hsieh CJ; Hou C; Lee H; Tomita C; Schmitz A; Plakas K; Dubroff JG; Mach RH Eur J Nucl Med Mol Imaging; 2024 May; ():. PubMed ID: 38722383 [TBL] [Abstract][Full Text] [Related]
9. mu-Opioid receptors and limbic responses to aversive emotional stimuli. Liberzon I; Zubieta JK; Fig LM; Phan KL; Koeppe RA; Taylor SF Proc Natl Acad Sci U S A; 2002 May; 99(10):7084-9. PubMed ID: 12011464 [TBL] [Abstract][Full Text] [Related]
10. Sex differences in the immune system: Implications for cocaine relapse. Reverte I; D'Ottavio G; Milella MS; Caprioli D Brain Behav Immun; 2022 Aug; 104():29-30. PubMed ID: 35580793 [No Abstract] [Full Text] [Related]
11. The molecular neurobiology and neuropathology of opioid use disorder. Blackwood CA; Cadet JL Curr Res Neurobiol; 2021; 2():. PubMed ID: 35548327 [TBL] [Abstract][Full Text] [Related]
12. Sex- and Brain Region-specific Changes in Gene Expression in Male and Female Rats as Consequences of Methamphetamine Self-administration and Abstinence. Daiwile AP; Jayanthi S; Cadet JL Neuroscience; 2021 Jan; 452():265-279. PubMed ID: 33242543 [TBL] [Abstract][Full Text] [Related]
13. A Survey of Molecular Imaging of Opioid Receptors. Cumming P; Marton J; Lilius TO; Olberg DE; Rominger A Molecules; 2019 Nov; 24(22):. PubMed ID: 31752279 [TBL] [Abstract][Full Text] [Related]
14. Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging? Colom M; Vidal B; Zimmer L Front Mol Neurosci; 2019; 12():255. PubMed ID: 31680859 [TBL] [Abstract][Full Text] [Related]
15. Naltrexone differentially modulates the neural correlates of motor impulse control in abstinent alcohol-dependent and polysubstance-dependent individuals. Nestor LJ; Paterson LM; Murphy A; McGonigle J; Orban C; Reed L; Taylor E; Flechais R; Smith D; Bullmore ET; Ersche KD; Suckling J; Elliott R; Deakin B; Rabiner I; Lingford Hughes A; Sahakian BJ; Robbins TW; Nutt DJ; Eur J Neurosci; 2019 Aug; 50(3):2311-2321. PubMed ID: 30402987 [TBL] [Abstract][Full Text] [Related]
17. Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study. Jayaram-Lindström N; Guterstam J; Häggkvist J; Ericson M; Malmlöf T; Schilström B; Halldin C; Cervenka S; Saijo T; Nordström AL; Franck J Transl Psychiatry; 2017 Apr; 7(4):e1104. PubMed ID: 28440810 [TBL] [Abstract][Full Text] [Related]
18. Toward biomarkers of the addicted human brain: Using neuroimaging to predict relapse and sustained abstinence in substance use disorder. Moeller SJ; Paulus MP Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt B):143-154. PubMed ID: 28322982 [TBL] [Abstract][Full Text] [Related]
19. Feeding-modulatory effects of mu-opioids in the medial prefrontal cortex: a review of recent findings and comparison to opioid actions in the nucleus accumbens. Selleck RA; Baldo BA Psychopharmacology (Berl); 2017 May; 234(9-10):1439-1449. PubMed ID: 28054099 [TBL] [Abstract][Full Text] [Related]
20. Prefrontal Cortical Opioids and Dysregulated Motivation: A Network Hypothesis. Baldo BA Trends Neurosci; 2016 Jun; 39(6):366-377. PubMed ID: 27233653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]